Shigeru Ohmori

2.9k total citations
132 papers, 2.3k citations indexed

About

Shigeru Ohmori is a scholar working on Pharmacology, Hepatology and Molecular Biology. According to data from OpenAlex, Shigeru Ohmori has authored 132 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 31 papers in Hepatology and 30 papers in Molecular Biology. Recurrent topics in Shigeru Ohmori's work include Pharmacogenetics and Drug Metabolism (44 papers), Liver Disease Diagnosis and Treatment (17 papers) and Drug Transport and Resistance Mechanisms (16 papers). Shigeru Ohmori is often cited by papers focused on Pharmacogenetics and Drug Metabolism (44 papers), Liver Disease Diagnosis and Treatment (17 papers) and Drug Transport and Resistance Mechanisms (16 papers). Shigeru Ohmori collaborates with scholars based in Japan, United States and Cameroon. Shigeru Ohmori's co-authors include Katsuya Shiraki, Takeshi Nakano, Takahisa Sakai, Mitsukazu Kitada, Kazushi Sugimoto, Hidekazu Inoue, Kazumoto Murata, Hiroshi Okano, Masatoshi Deguchi and Tamihide Matsunaga and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biochemistry.

In The Last Decade

Shigeru Ohmori

131 papers receiving 2.2k citations

Peers

Shigeru Ohmori
Comparison fields: 5 of 117
  • Pharmacology 648
  • Hepatology 612
  • Molecular Biology 598
  • Oncology 428
  • Surgery 411
Replace Mark Avigan with:
Mark Avigan United States
Yves Horsmans Belgium
Douglas L. Schmucker United States
Natascha C. Nüssler Germany
Caroline Aninat France
Jocelyn Trottier Canada
Behnam Saberi United States
Naomi Tanaka Japan
Francisco Javier Cubero Spain
Yasushi Matsuzaki Japan
Mark Avigan United States View profile →
Citations per field, relative to Shigeru Ohmori
Shigeru Ohmori · 1×
Citations per year, relative to Shigeru Ohmori
Shigeru Ohmori · 1×

Countries citing papers authored by Shigeru Ohmori

Since Specialization
Citations

This map shows the geographic impact of Shigeru Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Ohmori more than expected).

Fields of papers citing papers by Shigeru Ohmori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Ohmori. The network helps show where Shigeru Ohmori may publish in the future.

Co-authorship network of co-authors of Shigeru Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Ohmori. A scholar is included among the top collaborators of Shigeru Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Ohmori. Shigeru Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Detecting Coadministered Drugs that Affect the Incidence of Long QT Syndrome Associated with Fluoroquinolone Antibiotics Using a Spontaneous Reporting System
2
2
[Desensitization Therapy for Osimertinib in Patients Who Developed Toxic Erythema - Two Case Reports].
1
3 4
4 19
5 6
6 20
7 1
8 21
9 3
10 64
11 1
12 0
13 159
14
Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
5
15 34
16 1
17 61
18 3
19 9
20
CHARACTERIZATION AND PURIFICATION OF VARIOUS CARBOXYLESTERASE ISOZYMES FROM RAT LIVER MICROSOME
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026